148 related articles for article (PubMed ID: 1905303)
1. T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis.
Raziuddin S; Shetty S; Ibrahim A
J Clin Immunol; 1991 Mar; 11(2):103-13. PubMed ID: 1905303
[TBL] [Abstract][Full Text] [Related]
2. Activated CD4-positive T-lymphocytes and impaired cell-mediated immunity in patients with carcinoma of the urinary bladder with schistosomiasis.
Raziuddin S; Shetty S; Ibrahim A; Patil K
Cancer; 1990 Feb; 65(4):931-9. PubMed ID: 1688730
[TBL] [Abstract][Full Text] [Related]
3. Phenotype, activation and lymphokine secretion by gamma/delta T lymphocytes from schistosomiasis and carcinoma of the urinary bladder.
Raziuddin S; Shetty S; Ibrahim A
Eur J Immunol; 1992 Feb; 22(2):309-14. PubMed ID: 1531634
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor levels and immune activation in patients with schistosomiasis and carcinoma of the urinary bladder.
Raziuddin S; Shetty S; Ibrahim A
Scand J Immunol; 1992 Jun; 35(6):637-41. PubMed ID: 1604238
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder.
Raziuddin S; Masihuzzaman M; Shetty S; Ibrahim A
J Clin Immunol; 1993 Jan; 13(1):23-9. PubMed ID: 8445042
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
Fagiolo E; Abenante L
Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
Moriya N; Sanjoh K; Yokoyama S; Hayashi T
J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
[TBL] [Abstract][Full Text] [Related]
9. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation.
Hashimoto S; Takahashi Y; Tomita Y; Hayama T; Sawada S; Horie T; McCombs CC; Michalski JP
Scand J Immunol; 1991 Apr; 33(4):393-403. PubMed ID: 2017664
[TBL] [Abstract][Full Text] [Related]
11. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
Ulmer AJ; Scholz W; Ernst M; Flad HD
Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
[TBL] [Abstract][Full Text] [Related]
12. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus.
Chang FY; Shaio MF
Diabetes Res Clin Pract; 1995 May; 28(2):137-46. PubMed ID: 7587921
[TBL] [Abstract][Full Text] [Related]
13. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
14. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
Yamashita T; Boros DL
J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
[TBL] [Abstract][Full Text] [Related]
15. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 modulates CD23 and HLA-DR expression on CD4+ T cells and promotes a Th-2 type citokine profile.
Fratazzi C; Carini C
Allergol Immunopathol (Madr); 1997; 25(4):189-98. PubMed ID: 9269509
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776
[TBL] [Abstract][Full Text] [Related]
20. The relation of HLA-DR antigen, lymphocytes and natural killer cells in human bilharzial bladder carcinoma.
Mangoud AM; Essa MH; Aly MA; el Gindy M; Morsy TA; Makarem SS
J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):895-902. PubMed ID: 2507658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
